These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 33415328)
1. Classification and gene selection of triple-negative breast cancer subtype embedding gene connectivity matrix in deep neural network. Liu J; Su R; Zhang J; Wei L Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33415328 [TBL] [Abstract][Full Text] [Related]
2. Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer. Liu YR; Jiang YZ; Xu XE; Yu KD; Jin X; Hu X; Zuo WJ; Hao S; Wu J; Liu GY; Di GH; Li DQ; He XH; Hu WG; Shao ZM Breast Cancer Res; 2016 Mar; 18(1):33. PubMed ID: 26975198 [TBL] [Abstract][Full Text] [Related]
3. Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection. Lehmann BD; Jovanović B; Chen X; Estrada MV; Johnson KN; Shyr Y; Moses HL; Sanders ME; Pietenpol JA PLoS One; 2016; 11(6):e0157368. PubMed ID: 27310713 [TBL] [Abstract][Full Text] [Related]
4. Expression of long non-coding RNA ENSG00000226738 (LncKLHDC7B) is enriched in the immunomodulatory triple-negative breast cancer subtype and its alteration promotes cell migration, invasion, and resistance to cell death. Beltrán-Anaya FO; Romero-Córdoba S; Rebollar-Vega R; Arrieta O; Bautista-Piña V; Dominguez-Reyes C; Villegas-Carlos F; Tenorio-Torres A; Alfaro-Riuz L; Jiménez-Morales S; Cedro-Tanda A; Ríos-Romero M; Reyes-Grajeda JP; Tagliabue E; Iorio MV; Hidalgo-Miranda A Mol Oncol; 2019 Apr; 13(4):909-927. PubMed ID: 30648789 [TBL] [Abstract][Full Text] [Related]
5. Gene and lncRNA co-expression network analysis reveals novel ceRNA network for triple-negative breast cancer. Le K; Guo H; Zhang Q; Huang X; Xu M; Huang Z; Yi P Sci Rep; 2019 Oct; 9(1):15122. PubMed ID: 31641220 [TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer. Rodríguez Bautista R; Ortega Gómez A; Hidalgo Miranda A; Zentella Dehesa A; Villarreal-Garza C; Ávila-Moreno F; Arrieta O Clin Epigenetics; 2018; 10():88. PubMed ID: 29983835 [TBL] [Abstract][Full Text] [Related]
7. A gene signature predicts response to neoadjuvant chemotherapy in triple-negative breast cancer patients. Zheng T; Pang Z; Zhao Z Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988073 [TBL] [Abstract][Full Text] [Related]
8. Gene regulatory pattern analysis reveals essential role of core transcriptional factors' activation in triple-negative breast cancer. Min L; Zhang C; Qu L; Huang J; Jiang L; Liu J; Pinello L; Yuan GC; Shou C Oncotarget; 2017 Mar; 8(13):21938-21953. PubMed ID: 28423538 [TBL] [Abstract][Full Text] [Related]
9. Identification of mRNA and non-coding RNA hubs using network analysis in organ tropism regulated triple negative breast cancer metastasis. Banerjee S; Kalyani Yabalooru SR; Karunagaran D Comput Biol Med; 2020 Dec; 127():104076. PubMed ID: 33126129 [TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA LRRC75A-AS1 facilitates triple negative breast cancer cell proliferation and invasion via functioning as a ceRNA to modulate BAALC. Li S; Wu D; Jia H; Zhang Z Cell Death Dis; 2020 Aug; 11(8):643. PubMed ID: 32811810 [TBL] [Abstract][Full Text] [Related]
11. Highly heterogeneous-related genes of triple-negative breast cancer: potential diagnostic and prognostic biomarkers. Liu Y; Teng L; Fu S; Wang G; Li Z; Ding C; Wang H; Bi L BMC Cancer; 2021 May; 21(1):644. PubMed ID: 34053447 [TBL] [Abstract][Full Text] [Related]
12. Landscape of toll-like receptors expression in tumor microenvironment of triple negative breast cancer (TNBC): Distinct roles of TLR4 and TLR8. Roychowdhury A; Jondhale M; Saldanha E; Ghosh D; Kumar Panda C; Chandrani P; Mukherjee N Gene; 2021 Aug; 792():145728. PubMed ID: 34022297 [TBL] [Abstract][Full Text] [Related]
13. Comprehensive Analysis of Differentially Expressed Profiles of lncRNAs/mRNAs and miRNAs with Associated ceRNA Networks in Triple-Negative Breast Cancer. Yang R; Xing L; Wang M; Chi H; Zhang L; Chen J Cell Physiol Biochem; 2018; 50(2):473-488. PubMed ID: 30308479 [TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNAs (lncRNAs) in triple negative breast cancer. Wang Q; Gao S; Li H; Lv M; Lu C J Cell Physiol; 2017 Dec; 232(12):3226-3233. PubMed ID: 28138992 [TBL] [Abstract][Full Text] [Related]
15. Differences in molecular features of triple-negative breast cancers based on the age at diagnosis. Gulbahce HE; Bernard PS; Weltzien EK; Factor RE; Kushi LH; Caan BJ; Sweeney C Cancer; 2018 Dec; 124(24):4676-4684. PubMed ID: 30311638 [TBL] [Abstract][Full Text] [Related]
16. Generation of an algorithm based on minimal gene sets to clinically subtype triple negative breast cancer patients. Ring BZ; Hout DR; Morris SW; Lawrence K; Schweitzer BL; Bailey DB; Lehmann BD; Pietenpol JA; Seitz RS BMC Cancer; 2016 Feb; 16():143. PubMed ID: 26908167 [TBL] [Abstract][Full Text] [Related]
17. High-throughput «Omics» technologies: New tools for the study of triple-negative breast cancer. Judes G; Rifaï K; Daures M; Dubois L; Bignon YJ; Penault-Llorca F; Bernard-Gallon D Cancer Lett; 2016 Nov; 382(1):77-85. PubMed ID: 26965997 [TBL] [Abstract][Full Text] [Related]
18. Integrative analysis of breast cancer profiles in TCGA by TNBC subgrouping reveals novel microRNA-specific clusters, including miR-17-92a, distinguishing basal-like 1 and basal-like 2 TNBC subtypes. Kalecky K; Modisette R; Pena S; Cho YR; Taube J BMC Cancer; 2020 Feb; 20(1):141. PubMed ID: 32085745 [TBL] [Abstract][Full Text] [Related]
19. A large collection of integrated genomically characterized patient-derived xenografts highlighting the heterogeneity of triple-negative breast cancer. Coussy F; de Koning L; Lavigne M; Bernard V; Ouine B; Boulai A; El Botty R; Dahmani A; Montaudon E; Assayag F; Morisset L; Huguet L; Sourd L; Painsec P; Callens C; Chateau-Joubert S; Servely JL; Larcher T; Reyes C; Girard E; Pierron G; Laurent C; Vacher S; Baulande S; Melaabi S; Vincent-Salomon A; Gentien D; Dieras V; Bieche I; Marangoni E Int J Cancer; 2019 Oct; 145(7):1902-1912. PubMed ID: 30859564 [TBL] [Abstract][Full Text] [Related]
20. Differential response to neoadjuvant chemotherapy among 7 triple-negative breast cancer molecular subtypes. Masuda H; Baggerly KA; Wang Y; Zhang Y; Gonzalez-Angulo AM; Meric-Bernstam F; Valero V; Lehmann BD; Pietenpol JA; Hortobagyi GN; Symmans WF; Ueno NT Clin Cancer Res; 2013 Oct; 19(19):5533-40. PubMed ID: 23948975 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]